Monument Therapeutics

Monument Therapeutics develops stratified treatments for central nervous system conditions using digital brain biomarkers.

Manchester, UK—Website

£2.6MTotal raised

Monument Therapeutics is a stratified medicine company applying digital biomarkers to neuroscience drug development. The firm focuses on matching patient sub-groups with targeted compounds.

Team

Jenny Barnett

Chief Executive Officer

Jenny is the chief executive officer of Monument Therapeutics and chief scientific officer at Five Lives. She also serves as a research fellow at the University of Cambridge and a by-fellow at Hughes Hall.